Genome Canada?s Genomic Applications Partnership Program (GAPP) funds research and development projects that support public-private innovation. Each project involves collaborations between academic researchers and industry receptors -- organizations positioned to apply research outcomes to address market opportunities or operational needs that have been identified by the private sector (these receptor organizations are hereafter referred to simply as "receptors"). These projects help leverage public investment in innovation, encourage industry investment in genomics and biotechnology research in Canada, and generate co investment in market-driven research and development (R&D). They improve knowledge transfer from public institutions to Canadian companies to commercialize cutting-edge research and support our innovation value chain.

To be eligible for GAPP funding, projects must meet all the following criteria: The project focuses on an innovation need defined by a receptor; It is partnership between a receptor and researcher (and, optionally, additional partners), with active and necessary roles for all partners (refer to the Project partners section on the next page); The receptor acts as Project Leader and is a Canadian for-profit enterprise (FPE); The researcher acts as Administrative Project Leader and is employed by an eligible institution (refer to Project partners section on the next page); The project supports the invention, development or commercialization of a genomics-based or -enabled, biotechnological innovation with a clearly articulated market opportunity; It will result in commercial and/or intellectual property (IP) outcomes that benefit the receptor; It has the potential to generate social and economic impacts and benefits (refer to the later section, Benefits to Canada and impact on receptor).

INDIRECT COSTS ARE NOT ELIGIBLE

LAURA RILEY | LRILEY@ONTARIOGENOMICS.CA
130 King Street West
The Exchange Tower, Suite 1202
TORONTO, Ontario, Canada
416 977-9582